{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:17:30Z","timestamp":1787671050217,"version":"build-2736575974"},"reference-count":26,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Clonal evolution in acute myeloid leukemia (AML) originates long before diagnosis and is a dynamic process that may affect survival. However, it remains uninvestigated during routine diagnostic workups. We hypothesized that the mutational status of bone marrow dysplastic cells and leukemic blasts, analyzed at the onset of AML using integrated multidimensional flow cytometry (MFC) immunophenotyping and fluorescence-activated cell sorting (FACS) with next-generation sequencing (NGS), could reconstruct leukemogenesis. Dysplastic cells were detected by MFC in 285 of 348 (82%) newly diagnosed patients with AML. Presence of dysplasia according to MFC and World Health Organization criteria had no prognostic value in older adults. NGS of dysplastic cells and blasts isolated at diagnosis identified 3 evolutionary patterns: stable (n\u00a0= 12 of 21), branching (n\u00a0= 4 of 21), and clonal evolution (n\u00a0= 5 of 21). In patients achieving complete response (CR), integrated MFC and FACS with NGS showed persistent measurable residual disease (MRD) in phenotypically normal cell types, as well as the acquisition of genetic traits associated with treatment resistance. Furthermore, whole-exome sequencing of dysplastic and leukemic cells at diagnosis and of MRD uncovered different clonal involvement in dysplastic myelo-erythropoiesis, leukemic transformation, and chemoresistance. Altogether, we showed that it is possible to reconstruct leukemogenesis in \u223c80% of patients with newly diagnosed AML, using techniques other than single-cell multiomics.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008141","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T19:07:24Z","timestamp":1665774444000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-8428","authenticated-orcid":false,"given":"Catia","family":"Simoes","sequence":"first","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-6059","authenticated-orcid":false,"given":"Maria-Carmen","family":"Chillon","sequence":"additional","affiliation":[{"name":"2Centro de Investigaci\u00f3n del C\u00e1ncer de Salamanca-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-4091","authenticated-orcid":false,"given":"David","family":"Mart\u00ednez-Cuadr\u00f3n","sequence":"additional","affiliation":[{"name":"3Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0374-3008","authenticated-orcid":false,"given":"Maria-Jos\u00e9","family":"Calasanz","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"},{"name":"4CIMA Lab Diagnostics, Universidad de Navarra, IDISNA, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Bel\u00e9n","family":"Vridiales","sequence":"additional","affiliation":[{"name":"2Centro de Investigaci\u00f3n del C\u00e1ncer de Salamanca-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-6384","authenticated-orcid":false,"given":"Iria","family":"Vazquez","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"},{"name":"4CIMA Lab Diagnostics, Universidad de Navarra, IDISNA, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Hern\u00e1ndez-Ruano","sequence":"additional","affiliation":[{"name":"2Centro de Investigaci\u00f3n del C\u00e1ncer de Salamanca-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8819-402X","authenticated-orcid":false,"given":"Be\u00f1at","family":"Ariceta","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-372X","authenticated-orcid":false,"given":"Paula","family":"Aguirre-Ruiz","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-2496","authenticated-orcid":false,"given":"Leire","family":"Burgos","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-1375","authenticated-orcid":false,"given":"Diego","family":"Alignani","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Sarvide","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-6692","authenticated-orcid":false,"given":"Sara","family":"Villar","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-5354","authenticated-orcid":false,"given":"Ana Alfonso","family":"Pierola","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-8790","authenticated-orcid":false,"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-8353","authenticated-orcid":false,"given":"Rosa","family":"Ayala","sequence":"additional","affiliation":[{"name":"5Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-0063","authenticated-orcid":false,"given":"Joaquin","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"5Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-1208","authenticated-orcid":false,"given":"Juan Miguel","family":"Bergua Burgues","sequence":"additional","affiliation":[{"name":"6Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Vives","sequence":"additional","affiliation":[{"name":"7Hospital Germans Trias i Pujol, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Perez-Simon","sequence":"additional","affiliation":[{"name":"8Hospital Universitario Virgen del Rocio, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-9449","authenticated-orcid":false,"given":"Maria","family":"Garcia-Fortes","sequence":"additional","affiliation":[{"name":"9Hospital Universitario Virgen de la Victoria, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-513X","authenticated-orcid":false,"given":"Teresa","family":"Bernal del Castillo","sequence":"additional","affiliation":[{"name":"10Hospital Central de Asturias, SPA, IUOPA, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-5050","authenticated-orcid":false,"given":"Mercedes","family":"Colorado","sequence":"additional","affiliation":[{"name":"11Hospital Universitario Marqu\u00e9s de Valdecilla, Cantabria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-5992","authenticated-orcid":false,"given":"Mayte","family":"Olave","sequence":"additional","affiliation":[{"name":"12Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Rodr\u00edguez-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"13Hospital Universitario de Basurto, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Labrador","sequence":"additional","affiliation":[{"name":"14Hospital Universitario de Burgos, Burgos, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-1072","authenticated-orcid":false,"given":"Marcos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"2Centro de Investigaci\u00f3n del C\u00e1ncer de Salamanca-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-4857","authenticated-orcid":false,"given":"Jes\u00fas F.","family":"San-Miguel","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1489-1177","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Sanz","sequence":"additional","affiliation":[{"name":"3Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-5593","authenticated-orcid":false,"given":"Pau","family":"Montesinos","sequence":"additional","affiliation":[{"name":"3Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-3815","authenticated-orcid":false,"given":"Bruno","family":"Paiva","sequence":"additional","affiliation":[{"name":"1Departamento de Hemato-Oncology, Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), Instituto de Investigaci\u00f3n Sanitaria de Navarra (IDISNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2023010416262068000_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27472-5","article-title":"Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia","volume":"12","author":"Benard","year":"2021","journal-title":"Nat Commun"},{"issue":"7834","key":"2023010416262068000_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"1","key":"2023010416262068000_bib3","first-page":"1","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"2023010416262068000_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","article-title":"Acute myeloid leukemia ontogeny is defined by distinct somatic mutations","volume":"125","author":"Lindsley","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2023010416262068000_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/modpathol.2015.55","article-title":"Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia","volume":"28","author":"Weinberg","year":"2015","journal-title":"Mod Pathol"},{"issue":"15","key":"2023010416262068000_bib6","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2010-04-279794","article-title":"Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS\/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as \u201cAML not otherwise specified\u201d (AML-NOS) or \u201cAML with myelodysplasia-related changes\u201d (AML-MRC)","volume":"116","author":"Miesner","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2023010416262068000_bib7","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"2023010416262068000_bib8","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"12","key":"2023010416262068000_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/cncr.33403","article-title":"A\u00a0phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia","volume":"127","author":"Vives","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"2023010416262068000_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41375-021-01435-7","article-title":"Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML","volume":"36","author":"Duchmann","year":"2021","journal-title":"Leukemia"},{"issue":"18","key":"2023010416262068000_bib11","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2009-08-240457","article-title":"Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)","volume":"115","author":"Falini","year":"2010","journal-title":"Blood"},{"issue":"7488","key":"2023010416262068000_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"issue":"1","key":"2023010416262068000_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41591-018-0267-4","article-title":"Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level","volume":"25","author":"Chen","year":"2019","journal-title":"Nat Med"},{"issue":"14","key":"2023010416262068000_bib14","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","article-title":"Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis","volume":"119","author":"Makishima","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2023010416262068000_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"2023010416262068000_bib16","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders","volume":"122","author":"Damm","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2023010416262068000_bib17","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","article-title":"Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML","volume":"111","author":"Sallmyr","year":"2008","journal-title":"Blood"},{"issue":"17","key":"2023010416262068000_bib18","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/bloodadvances.2021004631","article-title":"Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia","volume":"5","author":"Stasik","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"2023010416262068000_bib19","first-page":"193","article-title":"Data-driven math model of FLT3-ITD acute myeloid leukemia reveals potential therapeutic targets","volume":"11","author":"Wooten","year":"2021","journal-title":"J\u00a0Pers Med"},{"issue":"suppl 1","key":"2023010416262068000_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood-2018-99-119806","article-title":"PTPN11 mutations confer unique metabolic properties and increase resistance to venetoclax and azacitidine in acute myelogenous leukemia","volume":"132","author":"Stevens","year":"2018","journal-title":"Blood"},{"issue":"18","key":"2023010416262068000_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1182\/blood.2020010483","article-title":"Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia","volume":"138","author":"Tanaka","year":"2021","journal-title":"Blood"},{"issue":"7","key":"2023010416262068000_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2015-10-677021","article-title":"Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML","volume":"127","author":"Wong","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2023010416262068000_bib23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"2023010416262068000_bib24","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.bbmt.2017.03.017","article-title":"Multicolor flow cytometry and multigene next-generation sequencing are complementary and highly predictive for relapse in acute myeloid leukemia after allogeneic transplantation","volume":"23","author":"Getta","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2023010416262068000_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bjh.17347","article-title":"Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia","volume":"192","author":"Loghavi","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2023010416262068000_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/bloodadvances.2019001181","article-title":"Single-cell mutational profiling enhances the clinical evaluation of AML MRD","volume":"4","author":"Ediriwickrema","year":"2020","journal-title":"Blood Adv"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/1\/167\/2027032\/blooda_adv-2022-008141-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/1\/167\/2027032\/blooda_adv-2022-008141-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:26:47Z","timestamp":1672849607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/1\/167\/486809\/Integrated-flow-cytometry-and-sequencing-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008141","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}